NCT00139672View on ClinicalTrials.gov

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

PHASE2CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

PD-217,014

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00139672 - A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS. | Biotech Hunter | Biotech Hunter